Quvium

  • Home
  • About
    • Team
    • Board of Directors
    • Clinical Advisory Board
    • Investor Opportunities
    • Health Care Professionals >
      • Overview
      • Clinical Studies
  • Respiratory Conditions
  • Our Solution
  • Testimonials
  • Contact Us
  • News and Blog
  • Privacy Policy
  • Home
  • About
    • Team
    • Board of Directors
    • Clinical Advisory Board
    • Investor Opportunities
    • Health Care Professionals >
      • Overview
      • Clinical Studies
  • Respiratory Conditions
  • Our Solution
  • Testimonials
  • Contact Us
  • News and Blog
  • Privacy Policy
Giving families peace of mind 
by providing a personalised early warning system

​​​Our technology explained
  • ​We use our groundbreaking technology to listen just for coughs and ignore all other background noise
  • Our device analyses a wearer's cough frequency and duration with proprietary algorithms
  • It then posts data packets to the server when a trigger (cough frequency change) is reached   
  • The server sends a text message to the patient or their caregiver if there are deviations from their pre-set baseline cough count. 
  • The server also keeps data for longitudinal reporting over time and for additional analysis to discover emerging trends
  • With permission the data can be shared with carers clinicians to support decision making
  • ​​A mobile and web app enable caregivers to view data and update information (such as people receiving text alerts)
Picture
Picture

​​


​Why early intervention is critical

​Studies show that for people with varying respiratory conditions, a cough can happen well before there are any breathing problems and can occur straight after exposure to a known trigger, such as exercise or pollen, or at the onset of a cold. Sonasure captures and analyses cough frequency and duration, a proven leading indicator that accurately detects early signs of respiratory compromise. 

We want to help sufferers with COPD, asthma and the elderly with respiratory risks. Of these populations, the poorly controlled or uncontrolled account for >14%, 18% and 10.5% respectively. Further, these patients are responsible for approximately 50% of hospitalisations of which 75% admittances are considered avoidable. These avoidable expenses in exceed £56+ billion annually.

Keep in touch 

If you are interested in the Sonasure cough monitor, we're putting the finishing touches on something life changing. Join the list to stay in the loop!
Subscribe to Newsletter

Address
Discovery Park
Ramsgate Road
Sandwich
Kent CT13 9ND

Contact Us 
Email - info@quvium.com
​
Telephone - 01304 802717

Find Us On